Entero Healthcare Solutions Limited IPO is a MAIN BOARD IPO. They are going to raise ₹1600 Crores via IPO. The issue is priced at ₹1195 to ₹1258 per equity share. The IPO is to be listed on NSE, BSE
Entero Healthcare Solutions Limited IPO opens for subscription on February 9, 2024, and closes on February 13, 2024. The allotment for the Entero Healthcare Solutions Limited IPO is expected to be finalized on February 14, 2024. Entero Healthcare Solutions Limited IPO will list on BSE, NSE with tentative listing date fixed as February 16, 2024.
| Entero Healthcare Solutions Limited | MAIN BOARD |
| Minimum Investment ₹13,838 / 1– Lot (11 shares) | Price Range ₹1195-₹1258 | |
| Max Quantity 14-Lots/ (154 Shares) | Max Investment ₹193,732 | Retail Discount ₹0 |
| Investor category and sub category Individual- HNI & Retail | Issue Size 1600 Cr | Employee Discount ₹ |
| Total Issue Size 12,718,600 Shares (Aggregating up to ₹1600.00 Cr) | Share Holding Pree Issue 35.350,636 | Issue Type Book build Issue IPO |
| Fresh Issue Share 7,949,125 Shares (Aggregating up to ₹1,000.00 Cr) | Share Holding Post Issue 44,966,020 | Listing At BSE, NSE |
| Offer For Sale 4,769,475 Shares of ₹10 (Aggregating up to ₹600.00 Cr) | Face value ₹10 |
IPO Dates
| Offer Starts | 09 Feb 2024 |
| Offer Ends | 13 Feb 2024 |
| Allotment | 14 Feb 2024 |
| Refunds | 15 Feb 2024 |
| Credit of shares to Demat account | 15 Feb 2024 |
| IPO Listing | 16 Feb 2024 |
About Entero Healthcare Solutions Limited
Incorporated in 2018, Entero Healthcare Solutions Limited is a distributor of healthcare products in India. The company’s technology-driven platform provides healthcare product distribution services to pharmacies, hospitals, and clinics throughout India.
As of March 31, 2023, 73 warehouses located across the country, last-mile delivery infrastructure, and relationships with pharmacies, hospitals, and clinics enable healthcare product manufacturers to make their products available to a wide range of customers. Similarly, the pharmacies, hospitals, and clinics that they service get access to a wide range of healthcare products through their distribution infrastructure and their healthcare product manufacturer relationships. During the Financial Years 2021, 2022, and 2023, they catered to over 39,500, 64,200, and 81,400 retail customers, respectively, and over 1,600, 2,500, and 3,400 hospital customers, respectively. Further, as of March 31, 2023, they have supply relationships with over 1,900 healthcare product manufacturers that give them access to over 64,500 product stock-keeping units (“SKUs”).
| Incorporated In | Managing Director |
| 2018 | Prabhat Agrawal |
Entero Healthcare Solutions Limited IPO Prospectus
| . | |
| DRHP Draft Prospectus | Click Here |
| RHP Draft Prospectus | Click Here |
Share Holding
| Share Holding Pre-Issue | 76.54% |
| Share Holding Post-Issue |
Financials
| Year | 2023 | 2022 | 2021 |
| Revenue | ₹3,305.72 | ₹2,526.55 | ₹1,783.67 |
| Assets | ₹1,308.73 | ₹1,125.98 | ₹833.79 |
| Profit | -₹11.10 | -₹29.44 | -₹15.35 |
| All values are in Rs. Cr |
Fundamentals
| Values | Values | ||
| Market cap | Cr | ROE | -2.66% |
| P/E (X) | ROCE | 6.06% | |
| POST P/E (X) | EPS | ||
| Debt to Equity | 0.45 | RONW | -1.86% |
Objects of the Issue
- Repayment/prepayment, in full or part, of certain borrowings availed of by the company and our Subsidiaries.
- Funding the long term working capital requirements.
- Pursuing inorganic growth initiatives through acquisitions.
- General corporate purposes.
Brokerage Firm IPO Review
- To be updated soon
| Entero Healthcare Solutions Limited Contact Details | |
| Address | Entero Healthcare Solutions Limited Plot No. I-35, Building – B Industrial Area Phase – I 13/7 Mathura Road, Faridabad 121 003 |
| Phone: | +91 22-69019100 |
| jayant.prakash@enterohealthcare.com | |
| Website | https://www.enterohealthcare.com/ |
| Entero Healthcare Solutions Limited IPO Lead Managers |
| ICICI Securities Limited Dam Capital Advisors Ltd Jefferies India Private Limited Jm Financial Limited SBI Capital Markets Limited |
| Entero Healthcare Solutions Limited IPO Registrar | |
| . | Link Intime India Private Ltd |
| Phone | +91-22-4918 6270 |
| Signatureglobal.ipo@linkintime.co.in | |
| Website | https://linkintime.co.in/ |
| Entero Healthcare Solutions Limited IPO Allotment Status Check |
| IPO Allotment Status Check Click Here |
Entero Healthcare Solutions Limited IPO FAQs
What is Entero Healthcare Solutions Limited IPO?
- Entero Healthcare Solutions Limited IPO is a MAIN BOARD IPO. They are going to raise ₹1600 Crores via IPO. The issue is priced at ₹1195 to ₹1258 per equity share. The IPO is to be listed on NSE, BSE
When Entero Healthcare Solutions Limited IPO will open?
- The IPO is to open on February 9, 2024, for QIB, NII, and Retail Investors.
What is Entero Healthcare Solutions Limited IPO Investors Portion?
- The investors’ portion for QIB is 75%, NII is 15%, and Retail is 10%.
What is Entero Healthcare Solutions Limited IPO Size?
- Entero Healthcare Solutions Limited IPO size is ₹1600 crores.
What is Entero Healthcare Solutions Limited IPO Price Band?
- Entero Healthcare Solutions Limited IPO Price Band is ₹1195 To ₹1258 per equity share.
What is Entero Healthcare Solutions Limited IPO Minimum and Maximum Lot Size?
- The IPO bid is Minimum 1-Lot (11 Shares) with ₹13,838. and Maximum Lot Size 14-Lots (154 Shares) with ₹193,732
What is Entero Healthcare Solutions Limited IPO Allotment Date?
- Entero Healthcare Solutions Limited IPO allotment date is February 14, 2024.
What is Entero Healthcare Solutions Limited IPO Listing Date?
- Entero Healthcare Solutions Limited IPO listing date is February 16, 2024. The IPO to list on NSE, BSE.